Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer's Disease.

International journal of biomedical investigation·2020
See all related articles

Related Experiment Video

Updated: Dec 24, 2025

A Neurite Outgrowth Assay and Neurotoxicity Assessment with Human Neural Progenitor Cell-Derived Neurons
07:41

A Neurite Outgrowth Assay and Neurotoxicity Assessment with Human Neural Progenitor Cell-Derived Neurons

Published on: August 6, 2020

7.9K

Thyroid Hormone Enhances Neurite Outgrowth in Neuroscreen 1 Cells.

Oldham Ce1, Wooten Cj1, Williams Ab1

  • 1Department of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise (BRITE), College of Arts and Sciences, North Carolina Central University, Durham, USA.

International Journal of Biomedical Investigation
|April 8, 2020
PubMed
Summary

Thyroid hormone (T3) promotes neurite outgrowth in cells and impacts tau splicing, suggesting a link between hypothyroidism and Alzheimer's disease (AD) risk.

Keywords:
Alzheimer’s diseaseAmyloid precursor proteinExon 10 splicingNS-1 cellTauThyroid hormones

More Related Videos

Author Spotlight: Unveiling the Molecular Basis of Pain Perception and Neuropathic Pain
05:28

Author Spotlight: Unveiling the Molecular Basis of Pain Perception and Neuropathic Pain

Published on: August 9, 2024

1.6K
Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

10.4K

Related Experiment Videos

Last Updated: Dec 24, 2025

A Neurite Outgrowth Assay and Neurotoxicity Assessment with Human Neural Progenitor Cell-Derived Neurons
07:41

A Neurite Outgrowth Assay and Neurotoxicity Assessment with Human Neural Progenitor Cell-Derived Neurons

Published on: August 6, 2020

7.9K
Author Spotlight: Unveiling the Molecular Basis of Pain Perception and Neuropathic Pain
05:28

Author Spotlight: Unveiling the Molecular Basis of Pain Perception and Neuropathic Pain

Published on: August 9, 2024

1.6K
Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

10.4K

Area of Science:

  • Neuroscience
  • Endocrinology
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) is a prevalent neurodegenerative disorder.
  • Hypothyroidism is a potential risk factor for AD development.

Purpose of the Study:

  • Investigate the correlation between thyroid hormone levels and proteins involved in AD pathology.
  • Examine the effect of 3,5,3'-triiodothyronine (T3) on neurite outgrowth and tau splicing.

Main Methods:

  • Cell culture with varying T3 levels.
  • Neurite outgrowth assays.
  • Quantitative real-time PCR for thyroid hormone receptor (TRα, TRβ) expression.
  • In-cell Western blotting for tau protein analysis.

Main Results:

  • T3 significantly enhanced neurite outgrowth in NS-1 cells.
  • NS-1 cells express TRα more than TRβ, mediating T3 effects.
  • T3 treatment altered tau exon 10 splicing, favoring the production of tau 3R.

Conclusions:

  • Findings suggest a molecular link between hypothyroidism and AD.
  • Results provide a basis for understanding AD in hypothyroid patients.
  • Potential implications for AD prevention and treatment strategies in at-risk populations.